HCW Biologics (HCWB) EPS (Basic) Growth (3y) (2023 - 2025)
HCW Biologics (HCWB) EPS (Basic) Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | -38.31% |
| 10 | HCW Biologics | 2.90 Mn | 2.16 Mn | -93,887.00 | 27.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.44% |
| Sep 30, 2025 | 24.48% |
| Jun 30, 2025 | -20.07% |
| Mar 31, 2025 | 72.14% |
| Dec 31, 2024 | 19.88% |
| Sep 30, 2024 | 9.34% |
| Jun 30, 2024 | 14.96% |
| Mar 31, 2024 | 33.55% |
| Dec 31, 2023 | -42.12% |
| Sep 30, 2023 | 32.79% |
| Jun 30, 2023 | 35.25% |